Matches in SemOpenAlex for { <https://semopenalex.org/work/W2616502721> ?p ?o ?g. }
- W2616502721 endingPage "1273" @default.
- W2616502721 startingPage "1259" @default.
- W2616502721 abstract "Intravitreal anti–vascular endothelial growth factor (VEGF) therapy is now considered the gold standard for the treatment of various retinal disorders. As therapy has evolved, so too have the treatment regimens employed by physicians in clinical practice; however, visual outcomes observed in the real world have typically not reflected those reported in clinical trials. Possible reasons for this include a lack of consensus on treatment regimens and a lack of clarity about what the aims of treatment should be. The Vision Academy Steering Committee met to discuss the principles of an ideal treatment regimen, using evidence from the literature to substantiate each point. Literature searches were performed using the MEDLINE/PubMed database (cut-off date: March 2016) and restricted to English-language publications. Studies with fewer than ten patients were excluded from this review. The Steering Committee identified the following four key principles for the ideal treatment regimen for anti-VEGF management of retinal diseases: It is proposed that the adoption of a proactive and more personalized approach in the clinic such as a treat-and-extend regimen will lead to benefits for both the patient and the physician, through a reduction in the associated treatment burden and better utilization of clinic resources. Implementation of the four principles should also lead to better VA outcomes for each patient, with a minimized risk of vision loss." @default.
- W2616502721 created "2017-05-26" @default.
- W2616502721 creator A5036443714 @default.
- W2616502721 creator A5045373262 @default.
- W2616502721 date "2017-05-19" @default.
- W2616502721 modified "2023-09-30" @default.
- W2616502721 title "Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti–vascular endothelial growth factor therapy of macular diseases" @default.
- W2616502721 cites W1500728559 @default.
- W2616502721 cites W1545259384 @default.
- W2616502721 cites W1563094820 @default.
- W2616502721 cites W1782061354 @default.
- W2616502721 cites W1782108791 @default.
- W2616502721 cites W1786299986 @default.
- W2616502721 cites W1815853970 @default.
- W2616502721 cites W1965018345 @default.
- W2616502721 cites W1968189763 @default.
- W2616502721 cites W1968756919 @default.
- W2616502721 cites W1971399814 @default.
- W2616502721 cites W1976154023 @default.
- W2616502721 cites W1978704499 @default.
- W2616502721 cites W1980725734 @default.
- W2616502721 cites W1982733715 @default.
- W2616502721 cites W1987183752 @default.
- W2616502721 cites W1987699263 @default.
- W2616502721 cites W1995067794 @default.
- W2616502721 cites W1996375155 @default.
- W2616502721 cites W1999610747 @default.
- W2616502721 cites W2003324689 @default.
- W2616502721 cites W2004117352 @default.
- W2616502721 cites W2004361001 @default.
- W2616502721 cites W2005009598 @default.
- W2616502721 cites W2011393181 @default.
- W2616502721 cites W2017194458 @default.
- W2616502721 cites W2028741508 @default.
- W2616502721 cites W2031617600 @default.
- W2616502721 cites W2040497439 @default.
- W2616502721 cites W2045057705 @default.
- W2616502721 cites W2046099308 @default.
- W2616502721 cites W2047554088 @default.
- W2616502721 cites W2047858191 @default.
- W2616502721 cites W2050020278 @default.
- W2616502721 cites W2052204551 @default.
- W2616502721 cites W2059889603 @default.
- W2616502721 cites W2066065593 @default.
- W2616502721 cites W2068742492 @default.
- W2616502721 cites W2074466053 @default.
- W2616502721 cites W2075984382 @default.
- W2616502721 cites W2081645048 @default.
- W2616502721 cites W2083043469 @default.
- W2616502721 cites W2085450444 @default.
- W2616502721 cites W2085712747 @default.
- W2616502721 cites W2091534585 @default.
- W2616502721 cites W2092252959 @default.
- W2616502721 cites W2098582960 @default.
- W2616502721 cites W2099927130 @default.
- W2616502721 cites W2102463203 @default.
- W2616502721 cites W2104740524 @default.
- W2616502721 cites W2105661731 @default.
- W2616502721 cites W2111693183 @default.
- W2616502721 cites W2115238232 @default.
- W2616502721 cites W2124415048 @default.
- W2616502721 cites W2126117364 @default.
- W2616502721 cites W2134161293 @default.
- W2616502721 cites W2138973020 @default.
- W2616502721 cites W2140018458 @default.
- W2616502721 cites W2146980524 @default.
- W2616502721 cites W2147222616 @default.
- W2616502721 cites W2157204458 @default.
- W2616502721 cites W2160226180 @default.
- W2616502721 cites W2160726762 @default.
- W2616502721 cites W2161069572 @default.
- W2616502721 cites W2161279821 @default.
- W2616502721 cites W2161487737 @default.
- W2616502721 cites W2166985747 @default.
- W2616502721 cites W2167801052 @default.
- W2616502721 cites W2172223254 @default.
- W2616502721 cites W2173144648 @default.
- W2616502721 cites W2177245277 @default.
- W2616502721 cites W2188489962 @default.
- W2616502721 cites W2191630306 @default.
- W2616502721 cites W2200149290 @default.
- W2616502721 cites W2265083335 @default.
- W2616502721 cites W2266679784 @default.
- W2616502721 cites W2289200040 @default.
- W2616502721 cites W2294113126 @default.
- W2616502721 cites W2316418129 @default.
- W2616502721 cites W2325448373 @default.
- W2616502721 cites W2337336780 @default.
- W2616502721 cites W2343042175 @default.
- W2616502721 cites W2485720608 @default.
- W2616502721 cites W2608488415 @default.
- W2616502721 cites W2616361514 @default.
- W2616502721 cites W2789226077 @default.
- W2616502721 cites W3350394 @default.
- W2616502721 cites W4236728865 @default.
- W2616502721 cites W4237391818 @default.
- W2616502721 cites W4244352700 @default.
- W2616502721 cites W4297917733 @default.